Angus Chemical Company acquires Expression Systems LLC

Angus Chemical Company, a global manufacturer and marketer of specialty ingredients for life science and industrial markets, has acquired Expression Systems LLC, a global manufacturer of cell culture media and related products and services. Angus is a portfolio company of Ardian and Golden Gate Capital.

Founded in 1997, Expression Systems is dedicated to providing and maintaining the baculovirus expression platform with innovative formulations of cell culture media, as well as cell lines, molecular tools, reagents and contract services. Expression Systems operates from a central headquarters in Davis, California, and is cGMP compliant and ISO 13485 certified for its manufacturing and research activities.

“The acquisition of Expression Systems is an important step in expanding Angus’ leadership position in life sciences beyond biological buffers to specialty cell culture media, a strategic contiguity with high overlap of customers and complementary product and service offerings,” said Angus’ CEO. David Neuberger. “The combination of Angus and Expression Systems further strengthens our ability to deliver value through consistent, high-quality ingredients and services critical to all phases of bioprocessing, from early-stage biologics development to large-scale commercial production.

Expression Systems is an independent supplier of specialty cell culture media and related products with a strong track record of product quality and innovation based on proprietary technology. The company specializes in baculovirus expression vector system (BEVS) and has deep expertise in the entire process, from gene optimization to protein purification. Expression Systems’ products are primarily used by structural biology researchers and biologics manufacturers to produce certain drug candidates, protein therapies, vaccines and gene therapies efficiently and cost-effectively.

“For more than 20 years, our dedicated family and employees have built a strong reputation with their customers by leveraging our world-renowned technical expertise in media fabrication and the baculovirus expression platform,” said David Hedin, president and CEO of Expression Systems. “As we considered the future of our business, it was clear that Angus was best placed to provide new opportunities for our current and new customers, as well as our employees. Angus will strengthen our position as a business dedicated global provider focused on segments of the biologics industry utilizing the baculovirus expression platform.”

Achelous Partners, LLC acted as exclusive M&A advisor to Expression Systems, LLC in connection with this transaction.